Shares of Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) dropped 21.9% during mid-day trading on Wednesday . The company traded as low as $0.38 and last traded at $0.38. Approximately 446 shares changed hands during mid-day trading, a decline of 9% from the average daily volume of 488 shares. The stock had previously closed at $0.4868.
Mosaic ImmunoEngineering Trading Down 21.9%
The firm has a market capitalization of $2.75 million, a P/E ratio of -4.22 and a beta of -0.84. The stock’s 50-day simple moving average is $0.65 and its 200-day simple moving average is $0.53.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last announced its earnings results on Wednesday, November 19th. The company reported ($0.02) earnings per share for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Recommended Stories
- Five stocks we like better than Mosaic ImmunoEngineering
- What is the Shanghai Stock Exchange Composite Index?
- Market Momentum: 3 Stocks Poised for Major Breakouts
- P/E Ratio Calculation: How to Assess Stocks
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- Roth IRA Calculator: Calculate Your Potential Returns
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
